Left Ventricular Hypertrophy
Showing 26 - 50 of >10,000
Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)
Not yet recruiting
- Aortic Valve Stenosis
- +5 more
- Valsartan
- Placebo Oral Tablet
-
Limoges, FranceLimoges university hospital
Dec 23, 2022
Fabry Disease, Fabry Disease, Cardiac Variant, Lysosomal Storage Diseases Trial in Wuerzburg (blood sampling
Enrolling by invitation
- Fabry Disease
- +4 more
- blood sampling (alpha-Galactosidase & LysoGb3)
-
Wuerzburg, Bavaria, GermanyUniversity Hospital Wuerzburg
Jul 2, 2021
Fabry's Disease Trial in Worldwide (Venglustat (GZ402671), Agalsidase alfa, Agalsidase beta (GZ419828))
Recruiting
- Fabry's Disease
- Venglustat (GZ402671)
- +3 more
-
Beijing, China
- +18 more
Jan 12, 2023
Heart Failure, Essential Hypertension Trial in Moscow (LCZ 696, Valsartan)
Recruiting
- Heart Failure
- Essential Hypertension
- LCZ 696
- Valsartan
-
Moscow, Russian FederationNational Medical Research Center for Cardiology
Jan 10, 2022
Cardiac Function in Extremely Preterm
Recruiting
- Left Ventricular Hypertrophy
- Echocardiography (ECHO) and lung ultrasound (LUS) studies before and after Dexamethasone administration
-
Montreal, Quebec, CanadaMontreal Children's hospital, Mcgill University Health Centre
Sep 10, 2021
Fabry Disease in Left Ventricular Hypertrophy Detected in
Recruiting
- Left Ventricular Hypertrophy
-
Yvoir, BelgiumCHU Dinant-Godinne
Feb 2, 2021
Native T1 CMR Imaging for Diagnosis of Cardiac Amyloidosis
Recruiting
- Heart Failure NYHA Class II
- +6 more
- Native T1 CMR
- +4 more
-
Leipzig, Saxony, GermanyUniversity of Leipzig
Nov 3, 2022
Hypertrophy, Left Ventricular Trial in L'Hospitalet de Llobregat (Everolimus, Mycophenolate mofetil, Tacrolimus)
Completed
- Hypertrophy, Left Ventricular
- Everolimus
- +2 more
-
L'Hospitalet de Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Jan 7, 2021
Hypertrophic Cardiomyopathy, Hypertrophic Obstructive Cardiomyopathy, Cardiomyopathy, Hypertrophic Trial (Squat-to-stand
Withdrawn
- Hypertrophic Cardiomyopathy
- +2 more
- Squat-to-stand maneuver
- +2 more
- (no location specified)
Dec 24, 2021
Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
- +3 more
- (no location specified)
Mar 2, 2023
Cardiovascular Diseases, Left Ventricular Hypertrophy Trial in Toronto, Keelung (Empagliflozin, Placebo)
Recruiting
- Cardiovascular Diseases
- Left Ventricular Hypertrophy
- Empagliflozin
- Placebo
-
Toronto, Ontario, Canada
- +3 more
Jun 14, 2021
MRI Sequence and Imaging Protocol Development
Unknown status
- Cardiomyopathy, Hypertrophic
- +4 more
- Cardiovascular Magnetic Resonance
-
Singapore, SingaporeNational Heart Centre Singapore
Mar 2, 2021
Hypertrophic Cardiomyopathy, Endothelial Dysfunction Trial in Pessac (BNP blood sample test, Electrocardiogram, Holter ECG)
Completed
- Hypertrophic Cardiomyopathy
- Endothelial Dysfunction
- BNP blood sample test
- +6 more
-
Pessac, FranceUniversity Hospital, Bordeaux
Feb 21, 2022
Hypertrophic Cardiomyopathy Trial in Adelaide (Perhexiline, Placebo)
Recruiting
- Hypertrophic Cardiomyopathy
- Perhexiline
- Placebo
-
Adelaide, South Australia, AustraliaFlinders Medical Centre
Mar 9, 2021
Aortic Stenosis, Left Ventricle Hypertrophied Trial in Aarhus (SGLT2 inhibitor, Placebo)
Recruiting
- Aortic Stenosis
- Left Ventricle Hypertrophied
- SGLT2 inhibitor
- Placebo
-
Aarhus, DenmarkAarhus University Hospital
Feb 11, 2022
Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD Study
Completed
- Heart Failure
- +3 more
- cardiac magnetic resonance (CMR) post haemodialysis
-
Frankfurt, Hessen, GermanyUniversity Hospital Frankfurt
Jun 14, 2021
Hypertrophy, Left Ventricular Trial in Worldwide (drug, procedure, radiation)
Active, not recruiting
- Hypertrophy, Left Ventricular
- mirabegron
- +6 more
-
Brussels, Belgium
- +8 more
Sep 28, 2021
Among, Serum Uric Acid, Left Ventricular Hypertrophy and
Unknown status
- Hyperuricemia
- Healthy
- Hyperuricemia
-
Taipei, Songshan Dist., TaiwanTri-service General Hospital, songshan branch
Jun 4, 2020
Physical Activity on Left Ventricular Mass and Lipid Metabolism
Terminated
- Left Ventricular Hypertrophy
- Exercise training, women, marathon
-
San Francisco, CaliforniaCTSI - University of California San Francisco
Jul 29, 2020
HOCM, Hypertrophic Obstructive Cardiomyopathy, LVOTO - Left Ventricular Outflow Tract Obstruction, Remodeling, Ventricular Trial
Recruiting
- HOCM, Hypertrophic Obstructive Cardiomyopathy
- +2 more
- PTSMA
-
Nieuwegein, Netherlands
- +1 more
Sep 8, 2021
Pediatric Left Ventricular Pressure Loading Lesions
Completed
- Coarctation of Aorta
- +2 more
- Echocardiogram
- Serology
-
Denver, ColoradoChildren's Hospital Colorado
Jan 14, 2021
Secondary Hyperparathyroidism, Chronic Kidney Disease Requiring Chronic Dialysis, Left Ventricular Hypertrophy Trial in Vienna
Completed
- Secondary Hyperparathyroidism
- +2 more
- cardiac MRI
- +4 more
-
Vienna, Austria
- +1 more
Jun 4, 2020
Left Ventricular Hypertrophy, Hypertension Trial in Italy (ACE inhibitor Ramipril, non-RAS inhibitor antihypertensive therapy)
Completed
- Left Ventricular Hypertrophy
- Hypertension
- ACE inhibitor Ramipril
- non-RAS inhibitor antihypertensive therapy
-
Ponte San Pietro, Bergamo, Italy
- +28 more
Jan 8, 2021
Heart Failure, Cardiac Resynchronization Therapy, Left Ventricular Septal Pacing Trial in Beijing (left ventricular septal
Not yet recruiting
- Heart Failure
- +3 more
- left ventricular septal pacing
- right ventricular apical pacing
-
Beijing, Beijing, ChinaFuwai hospital
Aug 3, 2023